|
|
News Breaks | | | | October 9, 2012 | | 06:54 EDT |  | SRPT, QCOR | Stocks with implied volatility below IV index mean; QCOR SRPT
Stocks with implied volatility below IV index mean; Questcor (QCOR), Sarepta (SRPT) according to iVolatility. | |
|
News For QCOR;SRPT From The Last 14 Days Check below for free stories on QCOR;SRPT the last two weeks. |
|
|
| June 19, 2013 | | 11:13 EDT |  | SRPT | Sarepta rises after reporting clinical data
 Subscribe for More Information | | | 09:54 EDT |  | SRPT | Sarepta data supports accelerated approval, says Piper Jaffray
Subscribe for More Information | | | 08:39 EDT | | SRPT | Sarepta eteplirsen demonstrates benefit on walking test in Phase IIb study
Sarepta Therapeutics announced updated data from Study 202, a Phase IIb open-label extension study of eteplirsen in patients with Duchenne muscular dystrophy, or DMD. Results at 84 weeks showed a continued stabilization of walking ability in eteplirsen-treated patients evaluable on the 6-minute walk test. As previously reported, Study 202 met its primary endpoint of increased novel dystrophin as assessed by muscle biopsy at Week 48 and is now in the long-term extension phase in which patients continue to be followed for safety and clinical outcomes. Eteplirsen is Sarepta's lead exon-skipping compound in development for the treatment of patients with DMD who have a genotype amenable to skipping of exon 51. | | | June 17, 2013 | | 12:20 EDT | | SRPT | Options with increasing implied volatility: WLT LNCO SRPT LINE
Subscribe for More Information | | | June 14, 2013 | | 11:23 EDT | | SRPT | Options with increasing implied volatility: TWO SRPT LNCO LINE DVA
| | | 06:15 EDT | | SRPT | Leerink remains cautious on accelerated approval for Sarepta
Subscribe for More Information | | | June 11, 2013 | | 16:21 EDT |  | QCOR | On The Fly: Closing Wrap
Stocks on Wall Street were lower after the Bank of Japan's decision to hold off on any further stimulus measures raised investor concern. The averages recovered much of their early losses in the morning, sitting just below the flat line near noon, but the selling intensified during the second half of the session, with the market trending lower into the close. ECONOMIC EVENTS: In the U.S., NFIB's small business optimism index rose to 94.4 in May from a prior 92.1 reading. Wholesale inventories rose 0.2% in April, matching expectations, and wholesale trade rose 0.5% from the prior month, versus expectations for a 0.1% slide. The Job Openings & Labor Turnover report for April showed openings fell 3% to a seasonally adjusted 3.75M, while hiring jumped nearly 5% to 4.4M. In Asia, the Bank of Japan refrained from changing its policies following recent volatility in its stock and bond markets. The dollar weakened considerably against the Yen, losing more than 2% to trade near the Y96 level. COMPANY NEWS: Sprint (S) shares jumped 17c, or 2.37%, to $7.35 after Japan's Softbank (SFTBF) increased its offer to acquire the telecom company in the face of a potential rival bid from DISH Network (DISH). MAJOR MOVERS: Among notable gainers was Questcor (QCOR), up $5.47, or 14.9%, to $42.18 after the company acquired the right to develop Synacthen from Novartis (NVS). Also higher was Catamaran (CTRX), up $5.33, or 10.95%, to $53.99 after the company struck a ten-year strategic pharmacy benefits agreement with Cigna (CI) and its stock received upgrades from at least three firms. Among noteworthy losers was lululemon (LULU), down $14.43, or 17.54%, to $67.85 after its CEO announced plans to step down and the stock was downgraded at Sterne Agee and UBS. Also lower was GenMark Diagnostics (GNMK) which lost $1.96, or 12.95%, to $13.17, after Natural Molecular Testing launched a cardiac testing panel using technology from GenMark's competitor Luminex (LMNX). INDICES: The Dow was down 116.57, or 0.76%, to 15,122.02; the Nasdaq was down 36.82, or 1.06%, to 3,436.95; and the S&P 500 was down 16.68, or 1.02%, to 1,626.13. | | | 12:59 EDT | | QCOR | Questcor price target raised to $54 from $35 at Ladenburg
Subscribe for More Information | | | 12:32 EDT | | QCOR | On The Fly: Midday Wrap
Stocks on Wall Street were lower at midday but well off their lows after the Bank of Japan held off from implementing any additional stimulus measures. The U.S. market followed Japan's benchmark stock index lower at the open, though the averages climbed back fairly steadily during the morning and stood near session highs just a bit below the flat line near noon. ECONOMIC EVENTS: In the U.S., NFIB's small business optimism index rose to 94.4 in May from a prior 92.1 reading. Wholesale inventories rose 0.2% in April, matching expectations, and wholesale trade rose 0.5% from the prior month, versus expectations for a 0.1% slide. The Job Openings & Labor Turnover report for April showed openings fell 3% to a seasonally adjusted 3.75M, while hiring jumped nearly 5% to 4.4M. In Asia, the Bank of Japan refrained from changing its policies following recent volatility in its stock and bond markets. The benchmark Nikkei fell about 1.5% as the decision disappointed investors who may have expected some action. COMPANY NEWS: Sprint (S) shares rose over 2% after Japan's Softbank (SFTBF) increased its offer to acquire the telecom company in the face of a potential rival bid from DISH Network (DISH). MAJOR MOVERS: Among the notable gainers was Catamaran (CTRX), which was upgraded by at least three Street firms and rose 11% after announcing a ten-year strategic pharmacy benefits deal with Cigna (CI). Also higher were shares of Questcor (QCOR), which jumped 19% after buying the rights to develop Synacthen from Novartis (NVS). Among the noteworthy losers was GenMark Diagnostics (GNMK), which fell 24% after Natural Molecular Testing launched a cardiac testing panel using technology from GenMark's competitor Luminex (LMNX). Also lower were shares of yoga apparel maker lululemon (LULU), which fell 17% after its CEO announced plans to step down and the stock was downgraded at Sterne Agee and UBS. INDICES: Near noon, the Dow was down 6.68, or 0.04%, to 15,231.91; the Nasdaq was down 11.21, or 0.32%, to 3,462.56; and the S&P 500 was down 4.89, or 0.30%, to 1,637.92. | | | 10:03 EDT |  | QCOR | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Outperform from Market Perform at Leerink... Arthur J. Gallagher (AJG) upgraded to Buy from Neutral at Goldman... Catamaran (CTRX) upgraded to Buy from Neutral at UBS... Disney (DIS) upgraded to Outperform from Neutral at Macquarie... Fly Leasing (FLY) upgraded to Buy from Neutral at Citigroup... Navistar (NAV) upgraded to Market Perform from Underperform... Questcor (QCOR) upgraded to Buy from Fair Value at CRT Capital... Talisman Energy (TLM) upgraded to Buy from Hold at Tudor Pickering... Synergetics (SURG) upgraded to Buy from Hold at Craig-Hallum... RBC Bearings (ROLL) upgraded to Outperform from Market Perform at Barrington. | | | | 09:16 EDT | | QCOR | On The Fly: Pre-market Movers
HIGHER: Dole Food (DOLE), up 21.9% after CEO offers buyout at $12 per share... Questcor (QCOR), up 32% after buying rights to develop Synacthen and Synacthen Depot in the U.S. from Novartis (NVS), upgrade to Buy at CRT Capital... CardioNet (BEAT), up 44% after announcing a three-year national provider agreement with UnitedHealthcare Insurance (UNH)... Catamaran (CTRX), up 13.2% after announcing a ten-year strategic pharmacy benefits deal with Cigna (CI)... Sprint (S), up 2% after Softbank (SFTBF) increases buyout offer terms. Clearwire (CLWR) up 1.2%. LOWER: lululemon (LULU), down 14.9% after reporting earnings, CEO announces plans to step down, stock downgraded at Sterne Agee and UBS... Texas Instruments (TXN), down 2% after narrowing second quarter revenue, earnings forecast ranges... Corinthian Colleges (COCO), down 15.4% after disclosing the receipt of a subpoena from the SEC. Corinthian peer Career Education (CECO) 5.5%... Kinross Gold (KGC), down 5.5% after canceling development project in Ecuador, taking $720M charge, stock downgraded at Canaccord. DOWN AFTER EARNINGS: LDK Solar (LDK), down 8.5%. | | | 08:48 EDT | | QCOR | Questcor upgraded to Buy from Fair Value at CRT Capital
CRT Capital upgraded Questcor after it acquired rights to Synacthen. Price target is $52. | | | 08:34 EDT | | QCOR | Questcor up 17% after buying Synacthen rights from Novartis
Subscribe for More Information | | | 07:02 EDT | | QCOR | Questcor acquires rights to develop Synacthen from Novartis
Subscribe for More Information | | | June 7, 2013 | | 13:30 EDT | | QCOR | Questcor rises after UnitedHealth issues policy update for Acthar
Subscribe for More Information | | | June 5, 2013 | | 13:29 EDT | | SRPT | Options with decreasing implied volatility: INFI SRPT GES SUPN CPRT
Subscribe for More Information | |
|
|
|
|
|
|
